Bluejay Diagnostics (BJDX) Cost of Revenue (2020 - 2024)

Bluejay Diagnostics has disclosed Cost of Revenue across 5 years of filings, most recently posting $816.0 for Q4 2024.

• Cost of Revenue for Q4 2024 came in at $816.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2024 was $8298.0 (changed N/A YoY), and the FY2024 annual result was $8297.0, down 97.07% from the prior year.
• Cost of Revenue came in at $816.0 for Q4 2024 at Bluejay Diagnostics, up from $753.0 in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $154329.0 in Q2 2023 to a low of $305.0 in Q2 2024.
• The 5-year median for Cost of Revenue is $53685.0 (2022), against an average of $61022.9.
• Across the five-year window, Cost of Revenue jumped 413.99% in 2021 and slumped 99.8% in 2024, its largest moves.
• Bluejay Diagnostics' Cost of Revenue stood at $19448.0 in 2020, then surged by 413.99% to $99961.0 in 2021, then soared by 46.16% to $146102.0 in 2022, then advanced by 5.63% to $154329.0 in 2023, then tumbled by 99.47% to $816.0 in 2024.
• The last three Cost of Revenue figures came in at $816.0 (Q4 2024), $753.0 (Q3 2024), and $305.0 (Q2 2024), per Business Quant data.